Summary

Persistence Market Research offers an in-depth analysis of the global Induced Pluripotent Stem Cells (iPSCs) Production Market, providing insights into market dynamics, key growth drivers, challenges, and emerging trends. This comprehensive report equips stakeholders with detailed data and statistics to navigate the market landscape from 2024 to 2032.

Key Insights:

• Estimated Market Value (2024): USD 1.2 Billion
• Projected Market Value (2032): USD 2.9 Billion
• Global Market Growth Rate (CAGR 2024 to 2032): 11.5%

iPSCs Production Market - Report Scope:

Induced pluripotent stem cells (iPSCs) are generated from adult cells reprogrammed to an embryonic stem cell-like state, offering immense potential for regenerative medicine, disease modeling, and drug discovery. The report covers various aspects of the iPSCs production market, including advancements in reprogramming technologies, increasing application in research and therapy, and growing investment in stem cell research. It also examines regulatory frameworks and ethical considerations impacting market dynamics.

Market Growth Drivers:

The iPSCs production market is driven by the expanding field of regenerative medicine and the need for personalized therapeutic approaches. Advancements in gene editing technologies, such as CRISPR-Cas9, enhance the precision and efficiency of iPSC reprogramming, boosting market growth. Increased funding and investment in stem cell research further propel the market, addressing the rising prevalence of chronic diseases and the need for innovative treatments.

Market Restraints:

Despite promising outlooks, the iPSCs production market faces challenges such as high production costs, technical complexities, and safety concerns related to genetic mutations and tumorigenicity. Ethical considerations and varying regulatory standards across regions can also limit market expansion. Additionally, the lack of standardized protocols affects research reproducibility and reliability.

Market Opportunities:

The iPSCs production market presents opportunities for innovation in reprogramming technologies and safer methods for iPSC generation. Emerging applications in organoid and tissue engineering, as well as personalized drug screening platforms, offer significant growth opportunities. Collaborations between academic institutions, research organizations, and biotechnology companies can drive innovation and accelerate commercialization.

Competitive Landscape and Business Strategies:

Leading companies such as FUJIFILM Cellular Dynamics, Lonza Group, and Takara Bio focus on product innovation, research, and strategic collaborations to maintain competitiveness. Strategic partnerships, mergers, acquisitions, and investments in clinical trials are employed to expand market presence and access new technologies.

Key Companies Profiled:

• FUJIFILM Cellular Dynamics, Inc.
• Lonza Group Ltd.
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• REPROCELL Inc.
• Stemcell Technologies Inc.
• Cellular Engineering Technologies Inc.
• Cynata Therapeutics Limited
• BrainXell, Inc.

iPSCs Production Market Segmentation:

By Product Type:

• Instruments/Devices
• Automated Platforms
• Consumables & Kits
• Kits
• Others
• Services

By Process:

• Manual
• Automated

By Workflow:

• Reprogramming
• Cell Culture
• Cell Characterization/Analysis
• Engineering
• Others

By Application:

• Drug Development and Discovery
• Regenerative Medicine
• Toxicology Studies
• Others

By Region:

• North America
• Latin America
• Europe
• APAC
• MEA

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Induced Pluripotent Stem Cells Production Market
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Bn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Induced Pluripotent Stem Cells Production Market, by Key Countries
4.2. Induced Pluripotent Stem Cells Production Market Opportunity Assessment (US$ Bn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Induced Pluripotent Stem Cells Production Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Induced Pluripotent Stem Cells Production Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Induced Pluripotent Stem Cells Production Market Demand Analysis 2019-2023 and Forecast, 2024-2032
6.1. Historical Market Analysis, 2019-2023
6.2. Current and Future Market Projections, 2024-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Induced Pluripotent Stem Cells Production Market Value Analysis 2019-2023 and Forecast, 2024-2032
7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Induced Pluripotent Stem Cells Production Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product Type, 2024-2032
8.3.1. Consumables & Kits
8.3.1.1. Media
8.3.1.2. Kits
8.3.1.3. Other Consumables & Kits
8.3.2. Instruments/Devices
8.3.3. Automated Platforms
8.3.4. Services
8.4. Market Attractiveness Analysis By Product Type
9. Global Induced Pluripotent Stem Cells Production Market Analysis 2019-2023 and Forecast 2024-2032, By Process
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Process, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Process, 2024-2032
9.3.1. Manual
9.3.2. Automated
9.4. Market Attractiveness Analysis By Process
10. Global Induced Pluripotent Stem Cells Production Market Analysis 2019-2023 and Forecast 2024-2032, By Workflow
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis By Workflow, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Workflow, 2024-2032
10.3.1. Reprogramming
10.3.2. Cell Culture
10.3.3. Cell Characterization/Analysis
10.3.4. Engineering
10.3.5. Other Workflows
10.4. Market Attractiveness Analysis By Workflow
11. Global Induced Pluripotent Stem Cells Production Market Analysis 2019-2023 and Forecast 2024-2032, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2032
11.3.1. Regenerative Medicine
11.3.2. Drug Development and Discovery
11.3.3. Toxicology Studies
11.3.4. Other Applications
11.4. Market Attractiveness Analysis By Application
12. Global Induced Pluripotent Stem Cells Production Market Analysis 2019-2023 and Forecast 2024-2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
12.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2024-2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Induced Pluripotent Stem Cells Production Market Analysis 2019-2023 and Forecast 2024-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Product Type
13.4.3. By Process
13.4.4. By Application
13.4.5. By Workflow
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Process
13.5.4. By Application
13.5.5. By Workflow
14. Latin America Induced Pluripotent Stem Cells Production Market Analysis 2019-2023 and Forecast 2024-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Product Type
14.4.3. By Process
14.4.4. By Application
14.4.5. By Workflow
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Process
14.5.4. By Application
14.5.5. By Workflow
15. Europe Induced Pluripotent Stem Cells Production Market Analysis 2019-2023 and Forecast 2024-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
15.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. U.K.
15.4.1.4. Italy
15.4.1.5. Benelux
15.4.1.6. Nordic Countries
15.4.1.7. Rest of Europe
15.4.2. By Product Type
15.4.3. By Process
15.4.4. By Application
15.4.5. By Workflow
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Process
15.5.4. By Application
15.5.5. By Workflow
16. Asia Pacific Induced Pluripotent Stem Cells Production Market Analysis 2019-2023 and Forecast 2024-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
16.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of Asia Pacific
16.4.2. By Product Type
16.4.3. By Process
16.4.4. By Application
16.4.5. By Workflow
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Process
16.5.4. By Application
16.5.5. By Workflow
17. Middle East and Africa Induced Pluripotent Stem Cells Production Market Analysis 2019-2023 and Forecast 2024-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
17.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Turkey
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Product Type
17.4.3. By Process
17.4.4. By Application
17.4.5. By Workflow
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product Type
17.5.3. By Process
17.5.4. By Application
17.5.5. By Workflow
18. Key Countries Induced Pluripotent Stem Cells Production Market Analysis 2019-2023 and Forecast 2024-2032
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US Induced Pluripotent Stem Cells Production Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.2.2.1. By Product Type
18.2.2.2. By Process
18.2.2.3. By Application
18.2.2.4. By Workflow
18.3. Canada Induced Pluripotent Stem Cells Production Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.3.2.1. By Product Type
18.3.2.2. By Process
18.3.2.3. By Application
18.3.2.4. By Workflow
18.4. Mexico Induced Pluripotent Stem Cells Production Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.4.2.1. By Product Type
18.4.2.2. By Process
18.4.2.3. By Application
18.4.2.4. By Workflow
18.5. Brazil Induced Pluripotent Stem Cells Production Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.5.2.1. By Product Type
18.5.2.2. By Process
18.5.2.3. By Application
18.5.2.4. By Workflow
18.6. Germany Induced Pluripotent Stem Cells Production Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.6.2.1. By Product Type
18.6.2.2. By Process
18.6.2.3. By Application
18.6.2.4. By Workflow
18.7. France Induced Pluripotent Stem Cells Production Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.7.2.1. By Product Type
18.7.2.2. By Process
18.7.2.3. By Application
18.7.2.4. By Workflow
18.8. Italy Induced Pluripotent Stem Cells Production Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.8.2.1. By Product Type
18.8.2.2. By Process
18.8.2.3. By Application
18.8.2.4. By Workflow
18.9. BENELUX Induced Pluripotent Stem Cells Production Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.9.2.1. By Product Type
18.9.2.2. By Process
18.9.2.3. By Application
18.9.2.4. By Workflow
18.10. UK Induced Pluripotent Stem Cells Production Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.10.2.1. By Product Type
18.10.2.2. By Process
18.10.2.3. By Application
18.10.2.4. By Workflow
18.11. Nordic Countries Induced Pluripotent Stem Cells Production Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.11.2.1. By Product Type
18.11.2.2. By Process
18.11.2.3. By Application
18.11.2.4. By Workflow
18.12. China Induced Pluripotent Stem Cells Production Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.12.2.1. By Product Type
18.12.2.2. By Process
18.12.2.3. By Application
18.12.2.4. By Workflow
18.13. Japan Induced Pluripotent Stem Cells Production Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.13.2.1. By Product Type
18.13.2.2. By Process
18.13.2.3. By Application
18.13.2.4. By Workflow
18.14. South Korea Induced Pluripotent Stem Cells Production Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.14.2.1. By Product Type
18.14.2.2. By Process
18.14.2.3. By Application
18.14.2.4. By Workflow
18.15. GCC Countries Induced Pluripotent Stem Cells Production Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.15.2.1. By Product Type
18.15.2.2. By Process
18.15.2.3. By Application
18.15.2.4. By Workflow
18.16. South Africa Induced Pluripotent Stem Cells Production Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.16.2.1. By Product Type
18.16.2.2. By Process
18.16.2.3. By Application
18.16.2.4. By Workflow
18.17. Turkey Induced Pluripotent Stem Cells Production Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
18.17.2.1. By Product Type
18.17.2.2. By Process
18.17.2.3. By Application
18.17.2.4. By Workflow
18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. LONZA
20.3.1.1. Product Portfolio
20.3.1.2. Key Strategies
20.3.1.3. Key Developments
20.3.2. AXOL BIOSCIENCES LTD
20.3.2.1. Product Portfolio
20.3.2.2. Key Strategies
20.3.2.3. Key Developments
20.3.3. EVOTEC
20.3.3.1. Product Portfolio
20.3.3.2. Key Strategies
20.3.3.3. Key Developments
20.3.4. HITACHI LTD
20.3.4.1. Product Portfolio
20.3.4.2. Key Strategies
20.3.4.3. Key Developments
20.3.5. REPROCELL INC
20.3.5.1. Product Portfolio
20.3.5.2. Key Strategies
20.3.5.3. Key Developments
20.3.6. FATE THERAPEUTICS.
20.3.6.1. Product Portfolio
20.3.6.2. Key Strategies
20.3.6.3. Key Developments
20.3.7. THERMO FISHER SCIENTIFIC, INC.
20.3.7.1. Product Portfolio
20.3.7.2. Key Strategies
20.3.7.3. Key Developments
20.3.8. MERCK KGAA (MILLIPORESIGMA)
20.3.8.1. Product Portfolio
20.3.8.2. Key Strategies
20.3.8.3. Key Developments
20.3.9. STEMCELLFACTORY III
20.3.9.1. Product Portfolio
20.3.9.2. Key Strategies
20.3.9.3. Key Developments
20.3.10. APPLIED STEMCELL INC.
20.3.10.1. Product Portfolio
20.3.10.2. Key Strategies
20.3.10.3. Key Developments
21. Assumptions and Acronyms Used
22. Research Methodology